Merck
HomeWebinars3D Printing - Shaping the Future of Formulation Development

3D Printing - Shaping the Future of Formulation Development



WEBINAR

We will review the existing technologies and outline the potential for the targeted application. An important aspect will be the filament-based 3D printing technology. A case study will be presented on how a hot-melt extrusion process can be optimized for filament production. Material properties, as well as downstream equipment, drive a successful implementation. We will also present a novel melt-based 3D printing approach, which can directly create the final dosage form out of powder. A drop-based deposition of the polymer melt ensures a new level of accuracy and individualization when it comes to the finishing of the final form.

In this webinar you will learn about:

  • Additive manufacturing: basics and potential application fields
  • Existing 3D printing approaches and their relevance in the pharmaceutical industry
  • The background and advantages of extrusion-based 3D printing
  • The requirements for FDM (fused deposition modeling) based technologies
  • New advanced technical approaches for direct shaping of 3D printed tablets

Speaker

Thomas Kipping, Ph.D.

Thomas Kipping, Ph.D.

Merck

Head of Drug Carriers

With a broad expertise in the field of solid dosage forms, Dr. Thomas Kipping provides a deep understanding of formulation development and process optimization in the complex area of solubility enhancement. He has a strong background in pharmaceutical industry, including industrial development, GMP manufacturing, clinical supply and research & development. Thomas is a pharmacist by education and holds a Ph.D. in Pharmaceutical Technology.